With no explanation, label each line with "other-disease", "O", "other-medical", "art-broadcastprogram", "art-film", "art-music", "art-other", "art-painting", "art-writtenart" or "building-airport" preceded by ":".
One
clinical
trial
of
ranibizumab
for
age-related
macular
degeneration
administered
intravitreally
reported
intraocular
inflammation
rates
between
1.4
%
and
2.9
%
.
One:O
clinical:O
trial:O
of:O
ranibizumab:other-medical
for:O
age-related:O
macular:other-disease
degeneration:other-disease
administered:O
intravitreally:O
reported:O
intraocular:O
inflammation:O
rates:O
between:O
1.4:O
%:O
and:O
2.9:O
%:O
.:O